Regulus Therapeutics Inc (RGLS)
2.27
+0.01
(+0.44%)
USD |
NASDAQ |
May 31, 16:00
2.295
+0.02
(+1.10%)
After-Hours: 20:00
Regulus Therapeutics Cash and Short Term Investments (Quarterly): 97.55M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 97.55M |
December 31, 2023 | 23.77M |
September 30, 2023 | 30.78M |
June 30, 2023 | 37.26M |
March 31, 2023 | 30.31M |
December 31, 2022 | 39.16M |
September 30, 2022 | 45.32M |
June 30, 2022 | 47.53M |
March 31, 2022 | 53.90M |
December 31, 2021 | 60.38M |
September 30, 2021 | 35.85M |
June 30, 2021 | 41.44M |
March 31, 2021 | 31.60M |
December 31, 2020 | 31.09M |
September 30, 2020 | 17.84M |
June 30, 2020 | 23.42M |
March 31, 2020 | 28.05M |
December 31, 2019 | 34.12M |
September 30, 2019 | 14.65M |
June 30, 2019 | 19.57M |
March 31, 2019 | 10.32M |
December 31, 2018 | 13.94M |
September 30, 2018 | 20.52M |
June 30, 2018 | 32.86M |
March 31, 2018 | 45.13M |
Date | Value |
---|---|
December 31, 2017 | 60.07M |
September 30, 2017 | 71.37M |
June 30, 2017 | 40.09M |
March 31, 2017 | 57.46M |
December 31, 2016 | 76.11M |
September 30, 2016 | 91.58M |
June 30, 2016 | 107.54M |
March 31, 2016 | 105.10M |
December 31, 2015 | 114.06M |
September 30, 2015 | 130.33M |
June 30, 2015 | 139.37M |
March 31, 2015 | 148.79M |
December 31, 2014 | 159.74M |
September 30, 2014 | 94.06M |
June 30, 2014 | 103.50M |
March 31, 2014 | 114.60M |
December 31, 2013 | 114.00M |
September 30, 2013 | 123.90M |
June 30, 2013 | 82.72M |
March 31, 2013 | 90.72M |
December 31, 2012 | 98.10M |
September 30, 2012 | 30.89M |
June 30, 2012 | 27.01M |
December 31, 2011 | 38.14M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
14.65M
Minimum
Sep 2019
97.55M
Maximum
Mar 2024
37.18M
Average
32.86M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
ACADIA Pharmaceuticals Inc | 470.52M |
Cassava Sciences Inc | 124.17M |
Vertex Pharmaceuticals Inc | 10.17B |
Cormedix Inc | 58.55M |
Oragenics Inc | 2.072M |